98 related articles for article (PubMed ID: 24247036)
1. Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17.
Yamashina M; Sato K; Tonogi M; Tanaka Y; Yamane GY; Katakura A
Acta Cytol; 2014; 58(1):67-75. PubMed ID: 24247036
[TBL] [Abstract][Full Text] [Related]
2. Differentiated vulvar intraepithelial neoplasia (dVIN): the most helpful histological features and the utility of cytokeratins 13 and 17.
Dasgupta S; Ewing-Graham PC; van Kemenade FJ; van Doorn HC; Noordhoek Hegt V; Koljenović S
Virchows Arch; 2018 Dec; 473(6):739-747. PubMed ID: 30187167
[TBL] [Abstract][Full Text] [Related]
3. Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.
Kitamura R; Toyoshima T; Tanaka H; Kawano S; Kiyosue T; Matsubara R; Goto Y; Hirano M; Oobu K; Nakamura S
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1299-310. PubMed ID: 22466643
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 13, Cytokeratin 17, Ki-67 and p53 Expression in Upper Layers of Epithelial Dysplasia Surrounding Tongue Squamous Cell Carcinoma.
Matsuhira A; Noguchi S; Sato K; Tanaka Y; Yamamoto G; Mishima K; Katakura A
Bull Tokyo Dent Coll; 2015; 56(4):223-31. PubMed ID: 26657521
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia.
Nobusawa A; Sano T; Negishi A; Yokoo S; Oyama T
Pathol Int; 2014 Jan; 64(1):20-7. PubMed ID: 24471966
[TBL] [Abstract][Full Text] [Related]
7. Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.
Yanagawa T; Yoshida H; Yamagata K; Onizawa K; Tabuchi K; Koyama Y; Iwasa S; Shimoyamada H; Harada H; Omura K
J Exp Clin Cancer Res; 2007 Jun; 26(2):215-20. PubMed ID: 17725101
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus.
Nazarian RM; Primiani A; Doyle LA; Linskey KR; Duncan LM; Odze RD; Zukerberg LR
Am J Surg Pathol; 2014 Jan; 38(1):78-85. PubMed ID: 24335642
[TBL] [Abstract][Full Text] [Related]
9. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
[TBL] [Abstract][Full Text] [Related]
11. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
Hasegawa H; Kusumi Y; Asakawa T; Maeda M; Oinuma T; Furusaka T; Oshima T; Esumi M
BMC Cancer; 2017 May; 17(1):381. PubMed ID: 28549422
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Cytokeratin 13 in Non-Neoplastic, Dysplastic and Neoplastic Oral Mucosa in a High Risk Pakistani Population.
Farrukh S; Syed S; Pervez S
Asian Pac J Cancer Prev; 2015; 16(13):5489-92. PubMed ID: 26225699
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo.
Wei KJ; Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Oral Dis; 2009 Jan; 15(1):111-7. PubMed ID: 18992022
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.
Hirabayashi T; Takahashi H; Watanabe M; Tachibana T
Hum Cell; 2017 Oct; 30(4):319-326. PubMed ID: 28260147
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of specific marker CK13 and CK10/13 combined with APM staining for the diagnosis of amniotic fluid embolism and aspiration.
Wang J; Lai Q; Pan H; Sun D; Yu C; Zhang W; Chen J; Ma L; Li L; Zhou R
Forensic Sci Int; 2014 May; 238():108-12. PubMed ID: 24705378
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining.
Ikeda Y; Suzuki T; Saitou H; Ogane S; Hashimoto K; Takano N; Nomura T
Int J Clin Oncol; 2020 Sep; 25(9):1604-1611. PubMed ID: 32451767
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions.
Yagyuu T; Obayashi C; Ueyama Y; Takano M; Tanaka Y; Kawaguchi M; Takeda M; Kasai T; Kirita T
J Oral Pathol Med; 2015 Aug; 44(7):523-31. PubMed ID: 25243470
[TBL] [Abstract][Full Text] [Related]
19. Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
Liang Y; Lü B; Zhou C
J Low Genit Tract Dis; 2019 Jan; 23(1):77-81. PubMed ID: 30106815
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin-17 as a potential marker for squamous cell carcinoma of the larynx.
Cohen-Kerem R; Madah W; Sabo E; Rahat MA; Greenberg E; Elmalah I
Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):821-7. PubMed ID: 15535145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
